| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/12/1999 | WO1999040080A1 Hydroxamic and carboxylic acid derivatives |
| 08/12/1999 | WO1999040073A2 Tryptase inhibitors |
| 08/12/1999 | WO1999039722A2 Compositions and methods for separating lens epithelial cells and preventing posterior capsular opacification |
| 08/12/1999 | WO1999029339A3 Prevention and/or treatment of allergic conditions |
| 08/12/1999 | WO1999002130A3 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 08/12/1999 | CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use |
| 08/12/1999 | CA2317476A1 Hydroxamic and carboxylic acid derivatives |
| 08/11/1999 | EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators |
| 08/11/1999 | EP0934336A1 Novel compounds |
| 08/11/1999 | EP0934335A1 Novel compounds |
| 08/11/1999 | EP0934305A1 Integrin antagonists |
| 08/11/1999 | EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 08/11/1999 | EP0934267A1 $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS |
| 08/11/1999 | EP0934259A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 08/11/1999 | EP0934079A1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta |
| 08/11/1999 | EP0756605B1 Peptides as therapeutic agents for the treatment of auto-immune diseases |
| 08/11/1999 | CN1225624A Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 08/11/1999 | CN1225623A Inhibition of matrix metalloproteases by acetylene contg. compounds |
| 08/11/1999 | CN1225622A Substituted oxobutyric acids as matrix metalloprotease inhibitor |
| 08/11/1999 | CN1225621A Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 08/11/1999 | CN1225620A Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/11/1999 | CN1225582A Use of carbonic anhydrase inhibitors for treating macular edema |
| 08/10/1999 | US5935931 Human apoptosis-related calcium-binding protein |
| 08/10/1999 | US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase. |
| 08/10/1999 | US5935820 Polynucleotides encoding vascular endothelial growth factor 2 |
| 08/10/1999 | US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds |
| 08/10/1999 | US5935604 A pulse effect, followed by controlled release and absorption of nicotine to provide a sustained high level of absorbed nicotine |
| 08/10/1999 | US5935585 Novel compounds useful in topical and systemic treatment of dermatological conditions associated with a keratinization disorder, and inflammatory or immunoallergenic component; body and hair care cosmetics |
| 08/05/1999 | WO1999039238A1 Methods and apparatus for accelerated orthokeratology |
| 08/05/1999 | WO1999038998A1 Methods of identifying modulators of kinases responsive to stress |
| 08/05/1999 | WO1999038882A1 Human cystatin f |
| 08/05/1999 | WO1999038850A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 08/05/1999 | WO1999038843A1 Hydroxamic and carboxylic acid derivatives |
| 08/05/1999 | WO1999038505A1 Compositions for prevention and treatment of cold and influenza-like symptoms associated with respiratory tract infections |
| 08/05/1999 | WO1999038497A2 Ophthalmic composition |
| 08/05/1999 | WO1999038492A1 Nasal solutions |
| 08/05/1999 | WO1999021538A3 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye |
| 08/05/1999 | CA2319087A1 Methods and apparatus for accelerated orthokeratology |
| 08/05/1999 | CA2319081A1 Human cystatin f |
| 08/05/1999 | CA2318516A1 Ophthalmic composition |
| 08/05/1999 | CA2317459A1 Methods of identifying modulators of kinases responsive to stress |
| 08/04/1999 | EP0933351A1 Tricyclic retinoids, methods for their production and use |
| 08/04/1999 | EP0933350A1 Tricyclic retinoids, methods for their production and use |
| 08/04/1999 | EP0932397A2 Medicinal aerosol formulations comprising budesonide |
| 08/04/1999 | EP0932389A1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum |
| 08/04/1999 | EP0740653B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 08/04/1999 | CN1225093A Benzo[g] quinoline derivatives |
| 08/04/1999 | CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 08/04/1999 | CN1224720A Tetracylic derivatives, process of preparation and use |
| 08/04/1999 | CN1224718A Thiazole derivatives |
| 08/03/1999 | US5932765 Nitromethyl ketones, process for preparing them and compositions containing them |
| 08/03/1999 | US5932737 Peptide compounds for treatment of no-mediated diseases |
| 08/03/1999 | US5932701 ribA |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | US5932595 Antiarthritic agent; multiple sclerosis; osteoporosis; respiratory system disorders; skin disorders; antiulcer agent |
| 08/03/1999 | US5932581 Administering sorbitol dehydrogenase inhibitor |
| 08/03/1999 | US5932549 Treating alzheimer*s disease, septic shock, acute myelogenous leukemia, stroke, and inflammatory bowel disease |
| 07/29/1999 | WO1999037668A1 Thrombin inhibitors |
| 07/29/1999 | WO1999037621A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/29/1999 | WO1999037319A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | WO1999037294A2 Mitochondria protecting agents for treating mitochondria associated diseases |
| 07/29/1999 | WO1999037292A2 Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina |
| 07/29/1999 | WO1999021617A3 Allosteric adenosine receptor modulators |
| 07/29/1999 | CA2319131A1 Mitochondria protecting agents for treating mitochondria associated diseases |
| 07/29/1999 | CA2318263A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | CA2318221A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/29/1999 | CA2317761A1 Thrombin inhibitors |
| 07/29/1999 | CA2317121A1 Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina |
| 07/28/1999 | EP0931788A2 Metalloprotease inhibitors |
| 07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
| 07/28/1999 | EP0931092A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 07/28/1999 | EP0931086A1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 07/28/1999 | EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 07/28/1999 | EP0931056A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
| 07/28/1999 | EP0931045A1 Matrix metalloproteinase inhibitors and their therapeutic uses |
| 07/28/1999 | EP0766665B1 Metalloproteinase inhibitors |
| 07/28/1999 | CN1224351A Pharmaceutical preparation contg. nimesulide for oral administration |
| 07/27/1999 | US5929249 Angiotensin ii receptor antagonists |
| 07/27/1999 | US5929247 Heterocyclic compounds and their preparation and use |
| 07/27/1999 | US5929045 Screening for bactericides |
| 07/27/1999 | US5929041 Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product |
| 07/27/1999 | US5929029 Human calcium-binding phosphoprotein |
| 07/27/1999 | CA2181175C Dihydro pyrazolopyrroles |
| 07/27/1999 | CA2016504C Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
| 07/22/1999 | WO1999036086A1 Lipooligosaccharide-based vaccine for prevention of moraxella (branhamella) catarrhalis infections in mammals |
| 07/22/1999 | WO1999036065A1 Medicinal compositions |
| 07/22/1999 | WO1999036055A1 Autoclavable pharmaceutical compositions containing a chelating agent |
| 07/22/1999 | WO1999036052A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
| 07/22/1999 | CA2317956A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
| 07/22/1999 | CA2315746A1 Lipooligosaccharide-based vaccine for prevention of moraxella (branhamella) catarrhalis infections in mammals |
| 07/21/1999 | EP0930071A1 Use of flavine-adenine-dinucleotide for the preparation of ophthalmic compositions for the treatment of the dry eye |
| 07/21/1999 | EP0930067A2 Mmp inhibitors for the treatment of ocular angiogenesis |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929542A1 Compounds for and a method of inhibiting matrix metalloproteinases |
| 07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929292A1 Method and composition for rewetting contact lenses and relieving eye dryness |
| 07/21/1999 | EP0745092B1 Peptide inhibitors of urokinase receptor activity |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |